FI890603A - Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi - Google Patents

Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi Download PDF

Info

Publication number
FI890603A
FI890603A FI890603A FI890603A FI890603A FI 890603 A FI890603 A FI 890603A FI 890603 A FI890603 A FI 890603A FI 890603 A FI890603 A FI 890603A FI 890603 A FI890603 A FI 890603A
Authority
FI
Finland
Prior art keywords
immunogen
hiv
retrovirus
infectious
useful
Prior art date
Application number
FI890603A
Other languages
English (en)
Swedish (sv)
Other versions
FI890603A0 (fi
FI95871B (fi
FI95871C (fi
Inventor
Jonas Salk
Dennis J Carlo
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Publication of FI890603A0 publication Critical patent/FI890603A0/fi
Publication of FI890603A publication Critical patent/FI890603A/fi
Publication of FI95871B publication Critical patent/FI95871B/fi
Application granted granted Critical
Publication of FI95871C publication Critical patent/FI95871C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
FI890603A 1987-06-10 1989-02-08 Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi FI95871C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US6028087A 1987-06-10 1987-06-10
US6028087 1987-06-10
US20075288A 1988-05-31 1988-05-31
US20075288 1988-05-31
PCT/US1988/001955 WO1988009670A1 (en) 1987-06-10 1988-06-09 Prevention and treatment of retroviral disease
US8801955 1988-06-09

Publications (4)

Publication Number Publication Date
FI890603A0 FI890603A0 (fi) 1989-02-08
FI890603A true FI890603A (fi) 1989-02-08
FI95871B FI95871B (fi) 1995-12-29
FI95871C FI95871C (fi) 1996-04-10

Family

ID=26739775

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890603A FI95871C (fi) 1987-06-10 1989-02-08 Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi

Country Status (14)

Country Link
EP (3) EP0317622B1 (fi)
JP (1) JPH0720880B2 (fi)
AT (1) ATE132374T1 (fi)
AU (1) AU612383B2 (fi)
CA (1) CA1336407C (fi)
DE (1) DE3854857T2 (fi)
DK (1) DK56389A (fi)
FI (1) FI95871C (fi)
IL (1) IL86675A (fi)
NO (1) NO175846C (fi)
OA (1) OA09037A (fi)
RU (1) RU2111010C1 (fi)
UA (1) UA27716C2 (fi)
WO (1) WO1988009670A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620804B2 (en) * 1987-03-23 1992-02-27 Hiver Limited Novel vaccines
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
WO1990015133A1 (en) * 1989-05-30 1990-12-13 Nippon Zeon Co., Ltd. Method of producing core structure of retro virus and particle produced thereby
FR2661834B1 (fr) * 1990-05-09 1995-01-27 Merieux Inst Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus.
AU4685293A (en) * 1992-07-20 1994-02-14 Immune Response Corporation, The Prophylactic and therapeutic control of retroviral infections
ATE189697T1 (de) * 1994-03-22 2000-02-15 Immune Response Corp Inc Die hocheffiziente herstellung und isolierung von viruspartikeln
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
ES8706824A1 (es) * 1985-04-08 1987-07-01 Genetic Systems Corp Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia.
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
EP0250128A3 (en) * 1986-06-18 1988-06-08 American Registry of Pathology Novel virus isolated from patients with aids
WO1988007058A1 (en) * 1987-03-16 1988-09-22 Biosolutions Pty. Ltd. Anti-paratopic antibody as an immunogen

Also Published As

Publication number Publication date
DK56389D0 (da) 1989-02-08
EP0317622A4 (en) 1990-05-14
UA27716C2 (uk) 2000-10-16
FI890603A0 (fi) 1989-02-08
EP0317622A1 (en) 1989-05-31
JPH0720880B2 (ja) 1995-03-08
FI95871B (fi) 1995-12-29
OA09037A (en) 1991-03-31
JPH02500440A (ja) 1990-02-15
EP0317622B1 (en) 1996-01-03
EP0602761A1 (en) 1994-06-22
IL86675A (en) 1993-04-04
NO890565D0 (no) 1989-02-09
ATE132374T1 (de) 1996-01-15
AU1962688A (en) 1989-01-04
NO175846C (no) 1994-12-21
DE3854857T2 (de) 1996-08-22
CA1336407C (en) 1995-07-25
NO890565L (no) 1989-02-09
AU612383B2 (en) 1991-07-11
NO175846B (fi) 1994-09-12
RU2111010C1 (ru) 1998-05-20
FI95871C (fi) 1996-04-10
DE3854857D1 (de) 1996-02-15
DK56389A (da) 1989-02-08
WO1988009670A1 (en) 1988-12-15
EP0685236A1 (en) 1995-12-06

Similar Documents

Publication Publication Date Title
ATE331026T1 (de) Antigen-markierte nicht-infektiöse retrovirus- ähnlige partikel
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
DK0584348T3 (da) Genetisk vaccine mod immundefektvirusser
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
SE9102974L (sv) Adenovira och vaerd till anvaendning foer framstaellning av hiv-proteiner och peptider
HUP9801242A1 (hu) Hepatitis B vakcina
DE69131200T2 (de) Herpes simplex virus vp16 impfstoffe
FI842215A (fi) Foerfarande foer framstaellning av levande effektiveringsvaccin och pao detta saett erhaollna vaccin.
FI890603A0 (fi) Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi
JPS5726624A (en) Isolation of virus glycoprotein antigen and manufacture of vaccine thereby
ATE105938T1 (de) Monoklonale antikörper gegen spezifische antigene regionen des humanen immundefizienzvirus und methoden zur verwendung.
ATE283066T1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
SE8701765L (sv) Analysmetod och medel foer denna
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
EP0250128A3 (en) Novel virus isolated from patients with aids
EP0320034A3 (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine
EP0309898A3 (en) Method for the induction of a cytotoxic t cell response
EP0513371A4 (en) Human parainfluenza virus type 4a fusion protein and gene which codes for the same
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.
AU6791290A (en) Antigens relating to envelope glyoprotein of the virus of aids, particularly precursors of this glycoprotein, methods of obtaining these antigens and means employed in these methods, applications of these antigens in the preparation of immunogenic compositions or for the diagnosis of aids or

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: THE IMMUNE RESPONSE CORPORATION, INC.

MA Patent expired